R. Henderson

发表

Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer

Zuofeng Li, W. Mendenhall, S. Flampouri, 2017, Acta oncologica.

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, American journal of clinical oncology.

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials

Zuofeng Li, W. Mendenhall, R. Marcus, 2013, Acta oncologica.

Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.

Zuofeng Li, C. Vargas, K. Olivier, 2008, International journal of radiation oncology, biology, physics.

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

W. Curran, D. Brachman, M. Mehta, 2008, International journal of radiation oncology, biology, physics.

Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.

Zuofeng Li, W. Mendenhall, S. Flampouri, 2015, International journal of radiation oncology, biology, physics.

Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2018, Acta oncologica.

Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014, American journal of clinical oncology.

Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer.

Zuofeng Li, C. Vargas, D. Indelicato, 2007, International journal of radiation oncology, biology, physics.

Proton therapy for lung cancer

Zuofeng Li, S. Flampouri, N. Mendenhall, 2012, Thoracic cancer.

Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate Cancer.

W. Mendenhall, N. Mendenhall, C. Morris, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Consensus Statement on Proton Therapy for Prostate Cancer

J. Liao, W. Mendenhall, N. Vapiwala, 2021, International journal of particle therapy.

Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of particle therapy.

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study

Zuofeng Li, S. Flampouri, C. Morris, 2020, International journal of particle therapy.

Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer

W. Mendenhall, N. Mendenhall, B. Hoppe, 2013, American journal of clinical oncology.

Hip fractures and pain following proton therapy for management of prostate cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013, Acta oncologica.

Elective ilioinguinal lymph node irradiation

R. Million, J. Parsons, R. Henderson, 1984 .

Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression.

Zuofeng Li, W. Mendenhall, R. Marcus, 2009, International journal of radiation oncology, biology, physics.

Insurance Approval for Definitive Proton Therapy for Prostate Cancer

W. Mendenhall, N. Mendenhall, C. Morris, 2021, International journal of particle therapy.

Management of Radiation Proctitis

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014, American journal of clinical oncology.

Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries

C. Simone, W. Hartsell, C. Vargas, 2019, Acta oncologica.

Outcomes in men with large prostates (≥ 60 cm3) treated with definitive proton therapy for prostate cancer

Zuofeng Li, W. Mendenhall, L. Mcgee, 2013, Acta oncologica.

When is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?

W. Mendenhall, N. Mendenhall, B. Hoppe, 2013, American journal of clinical oncology.

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

Zuofeng Li, W. Mendenhall, R. Marcus, 2013, Acta oncologica.

Testosterone Replacement Therapy in Men with Prostate Cancer after Proton Therapy

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2014 .

Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate Cancer.

W. Mendenhall, N. Mendenhall, C. Morris, 2016, International journal of particle therapy.

Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity.

N. Vapiwala, A. Butala, N. Mendenhall, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of radiation oncology, biology, physics.

Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer

W. Mendenhall, N. Mendenhall, C. Morris, 2021, Acta oncologica.

Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement

W. Mendenhall, N. Mendenhall, C. Morris, 2018, American journal of clinical oncology.

Controversies in proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, Chinese clinical oncology.

Protons Safely Allow Coverage of High-Risk Nodes for Patients with Regionally Advanced Non-Small-Cell Lung Cancer

S. Flampouri, N. Mendenhall, Z. Li, 2011, Technology in cancer research & treatment.

Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.

Zuofeng Li, Stella Flampouri, Zuofeng Li, 2011, Clinical lung cancer.

Hemorrhagic Radiation Cystitis

W. Mendenhall, N. Mendenhall, B. Hoppe, 2015, American journal of clinical oncology.

Proton therapy for prostate cancer.

Zuofeng Li, Zuofeng Li, W. Mendenhall, 2011, Oncology.

Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes

Perry B. Johnson, H. Wolfsen, J. Jones, 2022, International journal of particle therapy.

Definitive Radiotherapy for Prostate Cancer

W. Mendenhall, N. Mendenhall, R. Henderson, 2008, American journal of clinical oncology.

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2021, International journal of particle therapy.

Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy

S. Flampouri, L. Mcgee, C. Morris, 2019, Acta oncologica.

Survival results in adult patients treated for medulloblastoma

M. Hazuka, J. Kinzie, R. Henderson, 1992, Cancer.

Sperm preservation and neutron contamination following proton therapy for prostate cancer study

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2017, Acta oncologica.

Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer

Zuofeng Li, C. Morris, B. Hoppe, 2020, Acta oncologica.

A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study.

Zuofeng Li, S. Flampouri, B. McCook, 2016, International journal of radiation oncology, biology, physics.

Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2019, Cancer investigation.

Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.

W. Curran, D. Brachman, M. Mehta, 2008, International journal of radiation oncology, biology, physics.

Is Radical Prostatectomy the “Gold Standard” for Localized Prostate Cancer?

W. Mendenhall, N. Mendenhall, R. Henderson, 2010, American journal of clinical oncology.

Sr/Y -Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002 .

Randomized Trial of 90 Sr / 90 Y-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002 .

Randomized Trial of 90Sr/90Y β-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

Richard R. Heuser, Theodore A. Bass, Jeffrey J. Popma, 2002 .

Measuring Radiation Toxicity Using Circulating Cell-Free DNA in Prostate Cancer Patients

P. Okunieff, R. Zlotecki, S. Swarts, 2019, International journal of particle therapy.

Bacterial Urinary Tract Infection after Fiducial Marker Placement or Prostate Biopsy

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014 .

A comparative study of prostate PTV margins for patients using hydrogel spacer or rectal balloon in proton therapy.

W. Mendenhall, N. Mendenhall, B. Hoppe, 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2019, Physics in medicine and biology.

Proton Therapy for Prostate Cancer Treatment Employing Online Image Guidance and an Action Level Threshold

J. Palta, Zuofeng Li, C. Vargas, 2009, American journal of clinical oncology.

Local salvage of radiorecurrent prostate cancer

W. Mendenhall, N. Mendenhall, R. Henderson, 2023, The Prostate.

Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results.

Zuofeng Li, S. Flampouri, N. Mendenhall, 2012, Clinical lung cancer.

Rationale and early outcomes for the management of thymoma with proton therapy.

S. Flampouri, B. Hoppe, R. Henderson, 2018, Translational lung cancer research.

Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, R. Marcus, 2012, International journal of radiation oncology, biology, physics.

Erectile Dysfunction After Radiotherapy for Prostate Cancer

W. Mendenhall, D. Indelicato, N. Mendenhall, 2009, American journal of clinical oncology.

Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of radiation oncology, biology, physics.

Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or HIFU

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013 .

Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton Therapy.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2017, International journal of particle therapy.

Patient-reported Hip Symptoms following Treatment with Proton Therapy for Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013 .

Postprostatectomy Radiotherapy for Prostate Cancer

W. Mendenhall, N. Mendenhall, S. Keole, 2009, American journal of clinical oncology.

Genitourinary Cancers Five-Year Biochemical Results , Toxicity , and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2022 .

Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2014, International journal of radiation oncology, biology, physics.

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

Randomized Trial of 90Sr/90Y &bgr;-Radiation Versus Placebo Control for Treatment of In-Stent Restenosis

P. Teirstein, S. Silber, M. Suntharalingam, 2002, Circulation.

(S016) Intermediate-risk prostate cancer: a medicare-based cost comparison of five radiotherapy regimens.

W. Mendenhall, N. Mendenhall, B. Hoppe, 2015, Oncology.

Prospective neurocognitive effects and quality of life (QOL) in patients with multiple brain metastases receiving whole brain radiation (WBRT) ± thalidomide on radiation therapy oncology group (RTOG) trial 0118.

W. Curran, M. Mehta, J. Knisely, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Elective ilioinguinal lymph node irradiation.

R. Million, J. Parsons, R. Henderson, 1984, International Journal of Radiation Oncology, Biology, Physics.

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger

Zuofeng Li, W. Mendenhall, R. Marcus, 2012, Cancer.

Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer

P. Okunieff, R. Zlotecki, S. Swarts, 2020, International journal of particle therapy.

Selective nodal irradiation of regionally advanced non‐small‐cell lung cancer with proton therapy and IMRT: A dosimetric comparison

Zuofeng Li, S. Flampouri, N. Mendenhall, 2012, Thoracic cancer.

Urethral catheterization facilitates preradiation fiducial marker placement in postprostatectomy patients.

N. Mendenhall, R. Henderson, Joseph A. Costa, 2012, Journal of endourology.

Postprostatectomy Radiotherapy for Prostate Cancer

N. Mendenhall, S. Keole, R. Henderson, 2009, American journal of clinical oncology.

Measuring Radiation Toxicity Using Circulating Cell-Free DNA in Prostate Cancer Patients

P. Okunieff, R. Zlotecki, S. Swarts, 2021, International journal of particle therapy.

Five-Year Outcomes From a Prospective Trial of Image Guided Accelerated Hypofractionated Proton Therapy for Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2015 .

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.

Zuofeng Li, W. Mendenhall, S. Flampouri, 2015, International journal of radiation oncology, biology, physics.